|
 Help
 Merz - our research for your health. Under physiological conditions, the NMDA receptor is blocked by magnesium ions, thereby protecting the neuron against glutamatergic excitotoxicity.
Help: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Help is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Help now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Help very serious, so that we can offer you the best drug for each treatment and therapy you need. Help and Merz means research for your health. High-quality products and information about Help can be found on our website. Visit us online and learn everything about Help from one of Germany's leading health care companies. Our contribution to Help: read here what we can do for you. Further links: Axura: Information for professionals.>>>
Under physiological conditions, the NMDA receptor is blocked by magnesium ions, thereby protecting the neuron against glutamatergic excitotoxicity.
Memantine , Alzheimer's Treatment . Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . Glutamate is the principal neurotransmitter in the brain. In the course of the disease, the chronic release of glutamate and the permanently increased intracellular calcium concentration leads to neuronal degeneration (neurodegeneration). A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . Glutamatergic overstimulation results in neuronal damage, a phenomenon that has been termed excitotoxicity. At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . Memantine is well tolerated even in long-term therapy. About 70 percent of all excitatory synapses in the central nervous system are stimulated by the neurotransmitter glutamate. In the course of the disease, the chronic release of glutamate and the permanently increased intracellular calcium concentration leads to neuronal degeneration (neurodegeneration). Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . Merz is a leader in the field of Alzheimer research and developed the first drug for the treatment of moderate to severe Alzheimer s. At the same time, Memantine reduces caregiver time by more than 50 hours a month. The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. During physiological learning and memory processes, high concentrations of synaptic glutamate are transiently released. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . The intracellular calcium pool is reduced, and the noise lower. The pathological, sustained release of low glutamate concentrations, from both neurones and surrounding glia cells, also displaces magnesium from the NMDA receptor channel. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. In contrast to first generation therapies, Memantine is likely to show neuroprotective effects at concentrations used in the treatment of Alzheimer s disease and to slow down disease progression. Gedächtnis , Demenz . The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Merz , Multi Infarct Dementia . Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . Glutamatergic overstimulation results in neuronal damage, a phenomenon that has been termed excitotoxicity. During learning and memory processes (i e transient high glutamate release), memantine - the fast, voltage-dependent NMDA-receptor antagonist - leaves the NMDA receptor for a short time. Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . Memantine produces symptomatic improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer s disease. Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . Alzheimer's Symptoms , Mental Confusion . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . Therapy , Help . Diagnosis , Information Literature . Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's .
 Help
|
